Skip to content

MaxAn Post Market Surveillance Validation

A Post Market Surveillance Validation to Evaluate the Effectiveness of the MaxAn Anterior Cervical Plate

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01343693
Acronym
MaxAn
Enrollment
119
Registered
2011-04-28
Start date
2011-06-30
Completion date
2018-01-31
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DDD, Deformity, Fracture, Tumor

Keywords

DDD, Deformity, Tumor, Fracture, Cervical

Brief summary

This study is being performed to document the outcomes of subjects using our MaxAn Anterior Cervical Plate and assess them for Adjacent level Disease. All subjects will be followed for 2 years.

Detailed description

The purpose of this Post Market Surveillance Validation is to document the performance and clinical outcomes of the MaxAn® Anterior Cervical Plate System. Dr. Park, et.al conducted a retrospective review and found a positive association between adjacent-level ossification following anterior cervical plate procedures and the plate-to-disc distance. 1 They concluded that when the anterior cervical plates were placed at least 5mm away from the adjacent disc spaces, there was a decrease in the likelihood of moderate-to-severe adjacent-level ossification. The design of the MaxAn Anterior Cervical Plate and accompanying technique allows this type of plate placement; therefore we will be looking at the radiographic outcomes of these subjects and comparing them to the retrospective chart review conducted by Dr. Park using the MaxAn Technique allows you to achieve plate placement of 5mm from the supraadjacent level which will help minimize the risk of adjacent level ossification.

Interventions

None listed

Sponsors

Zimmer Biomet
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Subject is scheduled to undergo a one to three-level primary spinal fusion surgery between the levels of C2-T1 (Cervical 2 to Thoracic 1) using the MaxAn® Anterior Cervical Plate System. * Subject has agreed to participate in this study, sign the informed consent and have agreed to return for the 6, 12 and 24 month follow-up visits. * Subjects or their representative must be willing and able to give informed consent.

Exclusion criteria

* Subject has spinal infection or inflammation at any level. * Subject is morbidly obese, defined as a BMI greater than 40. * Subject has a mental illness, alcoholism or drug abuse. * Subject has a metal sensitivity/foreign body sensitivity. * Subject has inadequate tissue coverage over the operative site. * Subject has an open wound local to the operative area, or rapid joint disease, bone absorption, osteopenia and/or osteoporosis. * Female subjects who are pregnant or plan to become pregnant in the next 24 months or who are lactating. * Subject who does not meet the specific indications for use of the MaxAn® Anterior Cervical Plate System. * Subjects participating in another clinical research study. * Any previous cervical spinal surgery.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Differing Severity of Adjacent Level Ossification24 MonthsQualitatively assessed by an independent Radiologist using lateral radiographs Grade 0 - None Grade 1 - Mild (if the ossification extended across \<50% of the disc space) Grade 2 - Moderate (if the ossification extended across ≥ 50% of the disc space) Grade 3 - Severe (if there is complete bridging of the adjacent disc space)

Secondary

MeasureTime frameDescription
Change in Neck Disability Index (NDI)24 MonthsThe Neck Disability Index (NDI) is a patient-completed, condition-specific functional status questionnaire with 10 items including pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. Each section is scored on a 0 to 5 rating scale, in which zero means 'No pain' and 5 means 'Worst imaginable pain', with the points summed to a total score. The test can be interpretated as a raw score, with a minimum score of 0 and a maximum score of 50. A higher score indicates more patient-rated disability. To use the NDI for patient decisions, a clinically important change was calculated as 5 points.

Countries

United States

Participant flow

Participants by arm

ArmCount
ACDF With MaxAn Plate
Any subject with DDD, tumor, deformity ot trauma to the cervical spine in which the investigator determines the subject will require an ACDF using the MaxAn Plate.
119
Total119

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyLost to Follow-up9

Baseline characteristics

CharacteristicACDF With MaxAn Plate
Age, Continuous54.3 years
BMI (kg/m^2)29.8 kg/m^2
STANDARD_DEVIATION 5.5
Employment Status
Currently Working
50 Participants
Employment Status
Disabled/Retired Due to Ill Health
28 Participants
Employment Status
Not Reported
8 Participants
Employment Status
Retired
23 Participants
Employment Status
Unemployed
7 Participants
Employment Status
Workers Compensation
3 Participants
Number of Operated Levels
One vertebral level
27 Participants
Number of Operated Levels
Three vertebral levels
23 Participants
Number of Operated Levels
Two vertebral levels
69 Participants
Previous Cervical Spine Surgery
No
95 Participants
Previous Cervical Spine Surgery
Yes
24 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United States
119 participants
Sex: Female, Male
Female
66 Participants
Sex: Female, Male
Male
53 Participants
Tobacco Use
Current
37 Participants
Tobacco Use
Never
52 Participants
Tobacco Use
Past
30 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 119
other
Total, other adverse events
83 / 119
serious
Total, serious adverse events
14 / 119

Outcome results

Primary

Number of Participants With Differing Severity of Adjacent Level Ossification

Qualitatively assessed by an independent Radiologist using lateral radiographs Grade 0 - None Grade 1 - Mild (if the ossification extended across \<50% of the disc space) Grade 2 - Moderate (if the ossification extended across ≥ 50% of the disc space) Grade 3 - Severe (if there is complete bridging of the adjacent disc space)

Time frame: 24 Months

Population: Ten of the 110 patients with 24 month follow up were not evaluated for this endpoint. Eight had missing radiographs and 2 had unevaluable radiographs.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
ACDF With MaxAn PlateNumber of Participants With Differing Severity of Adjacent Level OssificationGrade 036 Participants
ACDF With MaxAn PlateNumber of Participants With Differing Severity of Adjacent Level OssificationGrade 138 Participants
ACDF With MaxAn PlateNumber of Participants With Differing Severity of Adjacent Level OssificationGrade 216 Participants
ACDF With MaxAn PlateNumber of Participants With Differing Severity of Adjacent Level OssificationGrade 310 Participants
ACDF With MaxAn PlateNumber of Participants With Differing Severity of Adjacent Level OssificationUnable to Assess2 Participants
ACDF With MaxAn PlateNumber of Participants With Differing Severity of Adjacent Level OssificationMissing Radiographs8 Participants
Secondary

Change in Neck Disability Index (NDI)

The Neck Disability Index (NDI) is a patient-completed, condition-specific functional status questionnaire with 10 items including pain, personal care, lifting, reading, headaches, concentration, work, driving, sleeping and recreation. Each section is scored on a 0 to 5 rating scale, in which zero means 'No pain' and 5 means 'Worst imaginable pain', with the points summed to a total score. The test can be interpretated as a raw score, with a minimum score of 0 and a maximum score of 50. A higher score indicates more patient-rated disability. To use the NDI for patient decisions, a clinically important change was calculated as 5 points.

Time frame: 24 Months

ArmMeasureValue (MEAN)Dispersion
ACDF With MaxAn PlateChange in Neck Disability Index (NDI)22.0 score on a scaleStandard Deviation 20

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026